These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
563 related items for PubMed ID: 25389366
1. CYP2J2 overexpression attenuates nonalcoholic fatty liver disease induced by high-fat diet in mice. Chen G, Xu R, Zhang S, Wang Y, Wang P, Edin ML, Zeldin DC, Wang DW. Am J Physiol Endocrinol Metab; 2015 Jan 15; 308(2):E97-E110. PubMed ID: 25389366 [Abstract] [Full Text] [Related]
2. CYP2J2 attenuates metabolic dysfunction in diabetic mice by reducing hepatic inflammation via the PPARγ. Li R, Xu X, Chen C, Wang Y, Gruzdev A, Zeldin DC, Wang DW. Am J Physiol Endocrinol Metab; 2015 Feb 15; 308(4):E270-82. PubMed ID: 25389363 [Abstract] [Full Text] [Related]
3. CYP2J2 overexpression ameliorates hyperlipidemia via increased fatty acid oxidation mediated by the AMPK pathway. Zhang S, Chen G, Li N, Dai M, Chen C, Wang P, Tang H, Hoopes SL, Zeldin DC, Wang DW, Xu X. Obesity (Silver Spring); 2015 Jul 15; 23(7):1401-13. PubMed ID: 26053032 [Abstract] [Full Text] [Related]
4. Cardiomyocyte-specific expression of CYP2J2 prevents development of cardiac remodelling induced by angiotensin II. He Z, Zhang X, Chen C, Wen Z, Hoopes SL, Zeldin DC, Wang DW. Cardiovasc Res; 2015 Mar 01; 105(3):304-17. PubMed ID: 25618409 [Abstract] [Full Text] [Related]
5. CYP2J2 and EETs Protect against Oxidative Stress and Apoptosis in Vivo and in Vitro Following Lung Ischemia/Reperfusion. Chen W, Zheng G, Yang S, Ping W, Fu X, Zhang N, Wang DW, Wang J. Cell Physiol Biochem; 2014 Mar 01; 33(6):1663-80. PubMed ID: 24903033 [Abstract] [Full Text] [Related]
6. Endothelium-specific CYP2J2 overexpression attenuates age-related insulin resistance. Yang Y, Dong R, Chen Z, Hu D, Fu M, Tang Y, Wang DW, Xu X, Tu L. Aging Cell; 2018 Apr 01; 17(2):. PubMed ID: 29318723 [Abstract] [Full Text] [Related]
8. NLRX1 knockout aggravates lipopolysaccharide (LPS)-induced heart injury and attenuates the anti-LPS cardioprotective effect of CYP2J2/11,12-EET by enhancing activation of NF-κB and NLRP3 inflammasome. Zhao G, Wang X, Edwards S, Dai M, Li J, Wu L, Xu R, Han J, Yuan H. Eur J Pharmacol; 2020 Aug 15; 881():173276. PubMed ID: 32574674 [Abstract] [Full Text] [Related]
9. Effects of Farnesoid X Receptor Activation on Arachidonic Acid Metabolism, NF-kB Signaling, and Hepatic Inflammation. Gai Z, Visentin M, Gui T, Zhao L, Thasler WE, Häusler S, Hartling I, Cremonesi A, Hiller C, Kullak-Ublick GA. Mol Pharmacol; 2018 Aug 15; 94(2):802-811. PubMed ID: 29743187 [Abstract] [Full Text] [Related]
10. The Effects of RKI-1447 in a Mouse Model of Nonalcoholic Fatty Liver Disease Induced by a High-Fat Diet and in HepG2 Human Hepatocellular Carcinoma Cells Treated with Oleic Acid. Wang J, Jiang W. Med Sci Monit; 2020 Feb 06; 26():e919220. PubMed ID: 32026851 [Abstract] [Full Text] [Related]
11. Ophiopogonin D Reduces Myocardial Ischemia-Reperfusion Injury via Upregulating CYP2J3/EETs in Rats. Huang X, Wang Y, Wang Y, Yang L, Wang J, Gao Y. Cell Physiol Biochem; 2018 Feb 06; 49(4):1646-1658. PubMed ID: 30227401 [Abstract] [Full Text] [Related]
12. CYP2J2 and EETs protect against lung ischemia/reperfusion injury via anti-inflammatory effects in vivo and in vitro. Chen W, Yang S, Ping W, Fu X, Xu Q, Wang J. Cell Physiol Biochem; 2015 Feb 06; 35(5):2043-54. PubMed ID: 25870948 [Abstract] [Full Text] [Related]
13. Cytochrome P450 2J2 is protective against global cerebral ischemia in transgenic mice. Li R, Xu X, Chen C, Yu X, Edin ML, Degraff LM, Lee CR, Zeldin DC, Wang DW. Prostaglandins Other Lipid Mediat; 2012 Dec 06; 99(3-4):68-78. PubMed ID: 23041291 [Abstract] [Full Text] [Related]
14. Vascular endothelial overexpression of human CYP2J2 (Tie2-CYP2J2 Tr) modulates cardiac oxylipin profiles and enhances coronary reactive hyperemia in mice. Hanif A, Edin ML, Zeldin DC, Morisseau C, Falck JR, Nayeem MA. PLoS One; 2017 Dec 06; 12(3):e0174137. PubMed ID: 28328948 [Abstract] [Full Text] [Related]
15. Epoxyeicosatrienoic acids alleviate methionine-choline-deficient diet-induced non-alcoholic steatohepatitis in mice. Wang X, Li L, Wang H, Xiao F, Ning Q. Scand J Immunol; 2019 Sep 06; 90(3):e12791. PubMed ID: 31132306 [Abstract] [Full Text] [Related]
16. Endothelial expression of human cytochrome P450 epoxygenase CYP2C8 increases susceptibility to ischemia-reperfusion injury in isolated mouse heart. Edin ML, Wang Z, Bradbury JA, Graves JP, Lih FB, DeGraff LM, Foley JF, Torphy R, Ronnekleiv OK, Tomer KB, Lee CR, Zeldin DC. FASEB J; 2011 Oct 06; 25(10):3436-47. PubMed ID: 21697548 [Abstract] [Full Text] [Related]
17. Taurine attenuates the development of hepatic steatosis through the inhibition of oxidative stress in a model of nonalcoholic fatty liver disease in vivo and in vitro. Murakami S, Ono A, Kawasaki A, Takenaga T, Ito T. Amino Acids; 2018 Sep 06; 50(9):1279-1288. PubMed ID: 29946793 [Abstract] [Full Text] [Related]
18. [The role of cytochrome P450 in nonalcoholic fatty liver induced by high-fat diet: a gene expression profile analysis]. Liu Y, Cheng F, Luo YX, Hu P, Ren H, Peng ML. Zhonghua Gan Zang Bing Za Zhi; 2017 Apr 20; 25(4):285-290. PubMed ID: 28494548 [Abstract] [Full Text] [Related]
19. Osteocalcin improves nonalcoholic fatty liver disease in mice through activation of Nrf2 and inhibition of JNK. Du J, Zhang M, Lu J, Zhang X, Xiong Q, Xu Y, Bao Y, Jia W. Endocrine; 2016 Sep 20; 53(3):701-9. PubMed ID: 26994931 [Abstract] [Full Text] [Related]
20. Cytochrome P450 epoxygenase CYP2J2 attenuates nephropathy in streptozotocin-induced diabetic mice. Chen G, Wang P, Zhao G, Xu G, Gruzdev A, Zeldin DC, Wang DW. Prostaglandins Other Lipid Mediat; 2011 Nov 20; 96(1-4):63-71. PubMed ID: 21742052 [Abstract] [Full Text] [Related] Page: [Next] [New Search]